Involvement of human endogenous retroviral syncytin-1 in human osteoclast fusion

Bone

Volumn 48, Issue 4, 2011, Pages 837-846

  Søe, Kent ^a   Andersen, Thomas L ^a   Hobolt Pedersen, Anne Sofie ^a   Bjerregaard Bolette, B ^b   Larsson, Lars Inge ^b   Delaissé, Jean Marie ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

ASCT2; Cell fusion; HERV W; Osteoclast; Syncytin 1

Indexed keywords

ACTIN; CELL PROTEIN; MESSENGER RNA; PEPTIDE; PROTEIN ASCT2; RECEPTOR PROTEIN; SYNCYTIN 1; SYNCYTIN 1 INHIBITORY PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; BONE BIOPSY; CELL DIFFERENTIATION; CELL FUSION; CELL INTERACTION; CELL MEMBRANE; CELL NUCLEUS; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; ILIAC CREST; OSTEOCLAST; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

AMINO ACID SEQUENCE; BLOTTING, WESTERN; CELL FUSION; CELLS, CULTURED; ENDOGENOUS RETROVIRUSES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE PRODUCTS, ENV; HUMANS; OSTEOCLASTS; POLYMERASE CHAIN REACTION; PREGNANCY PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 79952702740     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.11.011     Document Type: Article

References (42)

1. Vignery A. Osteoclasts and giant cells: macrophage-macrophage fusion mechanism. Int J Exp Pathol 2000, 81:291-304.
2. Vignery A. Macrophage fusion: are somatic and cancer cells possible partners?. Trends Cell Biol 2005, 15:188-193.
3. Vignery A. Macrophage fusion: the making of osteoclasts and giant cells. J Exp Med 2005, 202:337-340.
4. Yagi M., Miyamoto T., Toyama Y., Suda T. Role of DC-STAMP in cellular fusion of osteoclasts and macrophage giant cells. J Bone Miner Metab 2006, 24:355-358.
5. Helming L., Gordon S. Molecular mediators of macrophage fusion. Trends Cell Biol 2009, 19:514-522.
6. Kim K., Lee S.H., Ha K.J., Choi Y., Kim N. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol Endocrinol 2008, 22:176-185.
7. Leung R., Wang Y., Cuddy K., Sun C., Magalhaes J., Grynpas M., et al. Filamin A regulates monocyte migration through Rho small GTPases during osteoclastogenesis. J Bone Miner Res 2010, 25:1077-1091.
8. Vallet S., Raje N., Ishitsuka K., Hideshima T., Podar K., Chhetri S., et al. MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts. Blood 2007, 110:3744-3752.
9. Bendre M.S., Montague D.C., Peery T., Akel N.S., Gaddy D., Suva L.J. Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. Bone 2003, 33:28-37.
10. Brazier H., Pawlak G., Vives V., Blangy A. The Rho GTPase Wrch1 regulates osteoclast precursor adhesion and migration. Int J Biochem Cell Biol 2009, 41:1391-1401.
11. Wu H., Xu G., Li Y.P. Atp6v0d2 is an essential component of the osteoclast-specific proton pump that mediates extracellular acidification in bone resorption. J Bone Miner Res 2009, 24:871-885.
12. Lee S.H., Rho J., Jeong D., Sul J.Y., Kim T., Kim N., et al. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med 2007, 12:1403-1409.
13. Blond J.L., Beseme F., Duret L., Bouton O., Bedin F., Perron H., et al. Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J Virol 1999, 73:1175-1185.
14. Mi S., Lee X., Li Xp., Veldman G.M., Finnerty H., Racie L., et al. Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 2000, 403:785-789.
15. Melikyan G.B. Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm. Retrovirology 2008, 5:111.
16. Gong R., Peng X., Kang S., Feng H., Huang J., Zhang W., et al. Structural characterization of the fusion core in syncytin, envelope protein of human endogenous retrovirus family W. Biochem Biophys Res Commun 2005, 331:1193-1200.
17. Voisset C., Blancher A., Perron H., Mandrand B., Mallet F., Paranhos-Baccala G. Phylogeny of a novel family of human endogenous retrovirus sequences, HERV-W, in humans and other primates. AIDS Res Hum Retroviruses 1999, 15:1529-1533.
18. Cheynet V., Oriol G., Mallet F. Identification of the hASCT2-binding domain of the Env ERVWE1/syncytin-1 fusogenic glycoprotein. Retrovirology 2006, 3:41.
19. Lavillette D., Marin M., Ruggieri A., Mallet F., Cosset F.L., Kabat D. The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/cell surface receptors. J Virol 2002, 76:6442-6452.
20. Tailor C.S., Nouri A., Zhao Y., Takeuchi Y., Kabat D. A sodium-dependent neutral-amino-acid transporter mediates infections of feline and baboon endogenous retroviruses and simian type D retroviruses. J Virol 1999, 73:4470-4474.
21. Blond J.L., Lavillette D., Cheynet V., Bouton O., Oriol G., Chapel-Fernandes S., et al. An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J Virol 2000, 74:3321-3329.
22. Chang C., Chen P.T., Chang G.D., Huang C.J., Chen H. Functional characterization of the placental fusogenic membrane protein syncytin. Biol Reprod 2004, 71:1956-1962.
23. Drewlo S., Leyting S., Kokozidou M., Mallet F., Potgens A.J.G. C-terminal truncations of syncytin-1 (ERVWE1 envelope) that increase its fusogenicity. Biol Chem 2006, 387:1113-1120.
24. Frendo J.L., Olivier D., Cheynet V., Blond J.L., Bouton O., Vidaud M., et al. Direct involvement of HERV-W Env glycoprotein in human trophoblast cell fusion and differentiation. Mol Cell Biol 2003, 23:3566-3574.
25. Larsson L.I., Bjerregaard B., Talts J.F. Cell fusions in mammals. Histochem Cell Biol 2008, 129:551-561.
26. Potgens A.J.G., Drewlo S., Kokozidou M., Kaufmann P. Syncytin: the major regulator of trophoblast fusion? Recent developments and hypotheses on its action. Hum Reprod Update 2004, 10:487-496.
27. Dupressoir A., Marceau G., Vernochet C., Bénit L., Kanellopoulos C., Sapin V., Heidmann T. Syncytin-A and syncytin-B, two fusogenic placenta-specific murine envelope genes of retroviral origin conserved in Muridae. Proc Natl Acad Sci USA 2005, 102:725-730.
28. Dupressoir A., Vernochet C., Bawa O., Harper F., Pierron G., Opolon P., et al. Syncytin-A knockout mice demonstrate the critical role in placentation of a fusogenic, endogenous retrovirus-derived, envelope gene. Proc Natl Acad Sci USA 2009, 106:12127-12132.
29. Bjerregaard B., Holck S., Christensen I.J., Larsson L.I. Syncytin is involved in breast cancer-endothelial cell fusions. Cell Mol Life Sci 2006, 63:1906-1911.
30. Larsson L.I., Bjerregaard B., Wulf-Andersen L., Talts J.F. Syncytin and cancer cell fusions. Sci World J 2007, 7:1193-1197.
31. Strick R., Ackermann S., Langbein M., Swiatek J., Schubert S.W., Hashemolhosseini S., et al. Proliferation and cell-cell fusion of endometrial carcinoma are induced by the human endogenous retroviral Syncytin-1 and regulated by TGF-beta. J Mol Med 2007, 85:23-38.
32. Yu C., Shen K., Lin M., Chen P., Lin C., Chang G.D., et al. GCMa regulates the syncytin-mediated trophoblastic fusion. J Biol Chem 2002, 277:50062-50068.
33. Boissy P., Andersen T.L., Abdallah B.M., Kassem M., Plesner T., Delaisse J.M. Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation. Cancer Res 2005, 65:9943-9952.
34. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
35. Andersen T.L., Soe K., Sondergaard T.E., Plesner T., Delaisse J.M. Myeloma cell-induced disruption of bone remodelling compartments leads to osteolytic lesions and generation of osteoclast-myeloma hybrid cells. Br J Haematol 2010, 148:551-561.
36. Boissy P., Andersen T.L., Lund T., Kupisiewicz K., Plesner T., Delaissé J.M. Pulse treatment with the proteasome inhibitor bortezomib inhibits osteoclast resorptive activity in clinically relevant conditions. Leuk Res 2008, 32:1661-1668.
37. Andersen T.L., Sondergaard T.E., Skorzynska K.E., Dagnaes-Hansen F., Plesner T.L., Hauge E.M., et al. A physical mechanism for coupling bone resorption and formation in adult human bone. Am J Pathol 2009, 174:239-247.
38. Baron R., Chakraborty M., Chatterjee D., Horne D., Lomri D., Ravesloot J. Biology of the osteoclast. Physiology and pharmacology of bone 1993, 111-147. Springer Verlag, Berlin. G. Mundy, T. Martin (Eds.).
39. Cui W., Cuartas E., Ke J., Zhang Q., Einarsson H.B., Sedgwick J.D., et al. CD200 and its receptor, CD200R, modulate bone mass via the differentiation of osteoclasts. Proc Natl Acad Sci USA 2007, 104:14436-14441.
40. Mensah K.A., Ritchlin C.T., Schwarz E.M. RANKL induces heterogeneous DC-STAMP(lo) and DC-STAMP(hi) osteoclast precursors of which the DC-STAMP(lo) precursors are the master fusogens. J Cell Physiol 2010, 223:76-83.
41. Hayward M.D., Potgens A.J., Drewlo S., Kaufmann P., Rasko J.E. Distribution of human endogenous retrovirus type W receptor in normal human villous placenta. Pathology 2007, 39:406-412.
42. Bjerregaard B., Talts B., Larsson J.F. The endogenous envelope protein syncytin is involved in myoblast fusion. Cell Fusions: Regulation and Control 2011, 267-275. Springer, New York. L.I. Larsson (Ed.).